CAS 1467093-03-3

N-[5-[3-[7-(3-Fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide

CAS : 1467093-03-3

Formule : C₂₉H₂₄FN₇O

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 505.5456

Ref: IN-DA01EO6V

N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide

CAS : 1467093-03-3

N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide

Degré de pureté : 97%

Masse moléculaire : 505.55g/mol

Ref: 54-PC108693

Adavivint

CAS : 1467093-03-3

Adavivint

Degré de pureté : ≥98%

Masse moléculaire : 505.55g/mol

Ref: 54-BUP12700

Adavivint

CAS : 1467093-03-3

Adavivint (Adavivint (SM04690)) (SM04690) is a Wnt pathway inhibitor.

Formule : C₂₉H₂₄FN₇O

Degré de pureté : 98.27% - 98.6%

Couleur et forme : Solid

Masse moléculaire : 505.55

Ref: TM-T5636

Adavivint

Produit contrôlé

CAS : 1467093-03-3

Formule : C₂₉H₂₄FN₇O

Couleur et forme : Neat

Masse moléculaire : 505.546

Ref: TR-A208260

Adavivint

CAS : 1467093-03-3

Adavivint is a genetically engineered human TNF-α protein. It is a recombinant human tumor necrosis factor alpha (TNF-α) that has been modified to be less immunogenic. Adavivint is not active in the absence of other growth factors and cytokines, but can activate cells in vitro to produce proinflammatory cytokines such as IL-1β, IL-6, IL-8, and IL-12. This protein also activates cell factor and other signaling pathways that lead to the release of intracellular stores of inflammatory molecules. The effective dose for Adavivint is still being determined in clinical trials.

Formule : C₂₉H₂₄FN₇O

Degré de pureté : Min. 95%

Masse moléculaire : 505.55 g/mol

Ref: 3D-SIC09303